NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
15.73
-0.56 (-3.44%)
At close: Aug 5, 2026, 4:00 PM EDT
15.73
0.00 (0.00%)
After-hours: Aug 5, 2026, 7:34 PM EDT

NeoGenomics Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, NeoGenomics stock has a consensus rating of "Buy" and an average price target of $19.72. The average 1-year stock price forecast is 25.37% higher than the current stock price, while the lowest is $16 (+1.72%) and the highest is $35 (+122.50%).

Price Target: $19.72 (+25.37%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$16$19.72$19$35
Change+1.72%+25.37%+20.79%+122.50%

Analyst Ratings

The average analyst rating for NeoGenomics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy446665
Buy222222
Hold774444
Sell000000
Strong Sell000000
Total131312121211

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Craig-Hallum
Craig-Hallum
Buy
Maintains
$17$19
BuyMaintains$17$19+20.79%Jul 29, 2026
BTIG
BTIG
Hold
Reiterates
n/a
HoldReiteratesn/an/aJul 29, 2026
Needham
Needham
Buy
Reiterates
$15$19
BuyReiterates$15$19+20.79%Jul 29, 2026
William Blair
William Blair
Hold
Maintains
n/a
HoldMaintainsn/an/aJul 29, 2026
TD Cowen
TD Cowen
Buy
Maintains
$19
BuyMaintains$19+20.79%Jul 29, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
804.16M
from 727.33M
Increased by 10.56%
Revenue Next Year
884.79M
from 804.16M
Increased by 10.03%
EPS This Year
0.18
from 0.12
Increased by 52.28%
EPS Next Year
0.34
from 0.18
Increased by 85.07%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
484.33M509.73M591.64M660.57M727.33M804.16M
Revenue Growth
8.97%5.24%16.07%11.65%10.11%10.56%
Gross Profit
187.06M187.90M244.60M290.10M313.89M364.79M
Gross Margin
38.62%36.86%41.34%43.92%43.16%45.36%
Operating Income
-118.75M-153.11M-96.65M-71.10M-69.65M-54.49M
Net Income
-8.35M-144.25M-87.97M-78.73M-108.03M-38.73M
EPS
----0.120.18
EPS Growth
----9.09%52.28%
Forward PE
266.98266.98266.98103.9183.5886.08
Free Cash Flow
-64.72M-30.50M-272.88K-1.93M17.20M23.01M
No. Analysts
-----12
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High805.4M
Avg804.2M
Low799.5M

Revenue Growth

Revenue Growth202620272028
High
10.7%
Avg
10.6%
Low
9.9%

EPS Forecast

EPS202620272028
High0.20
Avg0.18
Low0.16

EPS Growth

EPS Growth202620272028
High
66.7%
Avg
52.3%
Low
33.3%